How Antidepressants Work

The Neurotransmitter Theory of Depression

Depression is associated with disruptions in the brain's chemical messaging systems. The leading pharmacological theory holds that imbalances in three neurotransmitters — serotonin, norepinephrine, and dopamine — play central roles.

Neurons communicate by releasing neurotransmitters into the gap (synapse) between nerve cells. The neurotransmitter crosses the synapse and binds to receptors on the next neuron, transmitting a signal. To end the signal, the releasing neuron pulls the neurotransmitter back in (a process called reuptake) and either recycles it or breaks it down.

Most modern antidepressants work by blocking reuptake transporters — preventing the neurotransmitter from being pulled back in, so it stays in the synapse longer, with a greater chance to exert its effect. The brain effectively experiences higher neurotransmitter activity without the body producing more of the chemical.

This is a simplified model. Depression involves complex changes in receptor sensitivity, neural circuit activity, neuroplasticity, and inflammatory processes — reuptake inhibition is the mechanism of the drug, but not the complete picture of why it helps depression.

How SSRIs Work

Selective serotonin reuptake inhibitors (SSRIs) — fluoxetine, sertraline, escitalopram, paroxetine, and others — are the most widely prescribed antidepressants.

The "selective" in SSRI refers to the drug's preference for the serotonin transporter (SERT) over norepinephrine and dopamine transporters. By blocking SERT, SSRIs increase serotonin availability in the synapses of brain circuits involved in mood, anxiety, and emotional processing.

Different SSRIs vary in their degree of selectivity and their activity at other receptors — which is why they have different side-effect profiles and different appropriateness for individual patients, despite sharing the same basic mechanism.

Common SSRI side effects (driven by serotonin activity across multiple receptor types): - Nausea (serotonin receptors in the gut) - Sexual dysfunction (serotonin's inhibitory effects on dopamine release in reward pathways) - Sleep changes (serotonin's role in sleep regulation) - Increased anxiety initially, settling after 2 weeks (activation of 5-HT2A receptors before 5-HT1A desensitization)

SNRIs and Dual Reuptake Inhibition

Serotonin-norepinephrine reuptake inhibitors (SNRIs) — venlafaxine, duloxetine, desvenlafaxine — block both SERT and the norepinephrine transporter (NET).

Adding norepinephrine reuptake inhibition provides additional pathways for antidepressant effect and is particularly useful for pain conditions (duloxetine is FDA-approved for diabetic neuropathy and fibromyalgia) and for patients who don't respond adequately to SSRIs alone.

Norepinephrine effects also explain some SNRI-specific side effects: increased blood pressure, faster heart rate, and sweating — effects driven by enhanced noradrenergic activity.

Other Antidepressant Classes

TCAs (Tricyclic Antidepressants): Older drugs (amitriptyline, nortriptyline, imipramine) that block serotonin and norepinephrine reuptake but also affect many other receptors — histamine (causing sedation), acetylcholine (causing dry mouth, constipation, urinary retention), and alpha-adrenergic receptors (causing orthostatic hypotension). These additional receptor effects make TCAs more difficult to tolerate but sometimes uniquely useful (e.g., amitriptyline at low doses for chronic pain or insomnia).

MAOIs (Monoamine Oxidase Inhibitors): Phenelzine, tranylcypromine, and selegiline block the enzyme that breaks down serotonin, norepinephrine, and dopamine — allowing all three to accumulate. Highly effective but dangerous in combination with certain foods (tyramine-rich foods like aged cheese) and many medications, as the combination can cause a hypertensive crisis. Rarely used as first-line treatment today.

Bupropion: Works primarily by blocking norepinephrine and dopamine reuptake, with minimal serotonin effect. Because it doesn't significantly increase serotonin, bupropion has a very different side-effect profile: minimal sexual dysfunction and weight gain (unlike SSRIs). It is also FDA-approved for smoking cessation.

Mirtazapine: Blocks presynaptic alpha-2 receptors (which normally suppress norepinephrine and serotonin release) and blocks certain serotonin receptor subtypes (5-HT2A, 5-HT3). The result is increased norepinephrine and serotonin, with fewer serotonin-mediated side effects. Also blocks histamine receptors, causing marked sedation and increased appetite — useful for patients with insomnia and poor appetite, but problematic for those prone to weight gain.

Receptor SelectivityReceptor Selectivity

The ability of a drug to preferentially bind to and affect one specific receptor type over others. Higher selectivity generally means fewer side effects because the drug acts more precisely on its int

and Side Effects

Receptor selectivity is the degree to which a drug targets one specific receptor versus related receptors. SSRIs are called "selective" because they preferentially hit SERT; tricyclics hit many transporters and receptors simultaneously.

Broader receptor activity generally means more side effects — but also sometimes more therapeutic versatility. A patient with depression, chronic pain, and insomnia might benefit from a TCA that addresses all three simultaneously, despite its more complex side-effect profile.

Why Antidepressants Take Weeks to Work

If SSRIs increase serotonin in synapses almost immediately (within hours of the first dose), why do they take 4–8 weeks to produce antidepressant effects?

The answer involves receptor adaptation. When serotonin levels are chronically elevated:

1. Presynaptic autoreceptors (5-HT1A on the releasing neuron) initially detect the higher serotonin levels and reduce serotonin firing — partially counteracting the drug's effect.
2. Over 2–4 weeks, these autoreceptors desensitize (downregulate) and stop suppressing serotonin release. Serotonin transmission genuinely increases.
3. Downstream changes in receptor sensitivity, gene expression, and neuroplasticity (including hippocampal neurogenesis) continue to develop over weeks.

This explains why stopping an SSRI because "it's not working after 2 weeks" is premature — the full therapeutic cascade is still developing.

Serotonin SyndromeSerotonin Syndrome

A potentially life-threatening condition caused by excessive serotonergic activity, usually from combining two or more drugs that increase serotonin levels. Symptoms include agitation, confusion, rapi

Serotonin syndrome is a potentially life-threatening drug reaction caused by too much serotonergic activity in the nervous system. It most commonly occurs when two serotonin-enhancing drugs are combined.

Classic triggers: - SSRI or SNRI combined with a MAOI - SSRI combined with tramadol (which inhibits serotonin reuptake) - SSRI combined with certain migraine medications (triptans — which are serotonin agonists) - SSRI combined with linezolid (an antibiotic with MAOI-like activity)

Symptoms range from mild (restlessness, mild tremor, diarrhea) to severe (high fever, seizures, muscle rigidity, irregular heartbeat). Severe serotonin syndrome is a medical emergency.

Always tell every healthcare provider about all your medications — including over-the-counterOver-the-Counter

Medications that can be purchased without a prescription, deemed safe for consumer use when following the label directions. The FDA determines OTC status based on a drug's safety profile, abuse potent

drugs, supplements, and herbal products. St. John's Wort, for example, is a serotonin reuptake inhibitor and can trigger serotonin syndrome when combined with SSRIs.

Key Takeaways

• Most antidepressants work by blocking neurotransmitter reuptake transporters — keeping serotonin, norepinephrine, or dopamine in the synapse longer.
• SSRIs selectively block serotonin reuptake; SNRIs block both serotonin and norepinephrine; bupropion targets norepinephrine and dopamine.
• Receptor selectivity determines side-effect profiles — drugs hitting more receptor types (like TCAs) have broader effects, both therapeutic and adverse.
• Antidepressants take 4–8 weeks to work because autoreceptor desensitization and neuroplasticity changes develop gradually, even though synapse serotonin increases quickly.
• Serotonin syndrome is a serious risk when serotonergic drugs are combined; always disclose all medications to your healthcare providers.